Forxiga

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

10 competitors in Glomerulonephritis

#DrugCompanyPhaseTrials

1

Fabhalta

Novartis

Approved

—2

Thalitone

Jazz Pharmaceuticals

Approved

—3

Deltasone

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Approved

—4

Decadron

AAspen Global Incorporated

Approved

—5

Kerendia

Bayer

Phase 2

16

Gazyva

Roche

Phase 2

17

KP104

KKira Pharmacenticals (US), LLC.

Phase 2

18

Forxiga

AstraZeneca

Phase 2

1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Type 1 Diabetes4 trials

Acute Effects of SGLT2 Inhibition on Renal Oxygenation and Autonomic Function in Type 1 Diabetes

Completed·SSteno Diabetes Center Copenhagen·Phase 4·NCT04193566·30 enrolled

Effects of Dapagliflozin on Hormonal Glucose Homeostasis in Type 1 Diabetes

Completed·IInsel Gruppe AG, University Hospital Bern·Phase 3·NCT04035031·13 enrolled

Dapagliflozin in Physical Exercise in Type 1 Diabetes

Completed·IInsel Gruppe AG, University Hospital Bern·Phase 3·NCT04049110·39 enrolled

Show 1 more trial

Evaluating Safe Ketone Thresholds To Minimise Ketosis in People With Type 1 Diabetes Using Dapagliflozin

Not yet recruiting·SSt Vincent's Hospital Melbourne·Phase 2·NCT07225465·115 enrolled

Type 2 Diabetes3 trials

Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing Metformin Monotherapy in Patients with Type 2 Diabetes Who Have Inadequate Glycemic Control

Completed·DDong-A ST Co., Ltd.·Phase 4·NCT05743907·231 enrolled

Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Forxiga

Completed·PPopulation Health Research Institute·Phase 4·NCT02561130·154 enrolled

Dapagliflozin in Type 2 Diabetes Patients, a Retrospective Cohort Study From Turkey

Completed·AstraZeneca··NCT03407196·1,683 enrolled

Diabetes Mellitus1 trial

Efficacy and Safety of Lima Association in the Control of Type II Diabetes Mellitus.

Withdrawn·EEMS·Phase 3·NCT03766750

Dapagliflozin1 trial

Bioequivalence Study of Combination Tablets of Saxagliptin / Dapagliflozin / Metformin XR (Extended-release) and Dapagliflozin / Metformin XR Relative to Individual Components in Healthy Subjects

Completed·AstraZeneca·Phase 1·NCT03138356·126 enrolled

Tics1 trial

Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects

Completed·DDong-A ST Co., Ltd.·Phase 1·NCT04473417·60 enrolled

2 more indications

Glomerulonephritis1 trial

Impact of Dapagliflozin for the Regulation of Immunological Activity in Membranous

Not yet recruiting·CCentre Hospitalier Universitaire de Nice·Phase 2·NCT07096986·20 enrolled

Unspecified1 trial

forREAL: FORXIGA PRESCRIPTION EVENT MONITORING PROGRAM (PEMP)

Terminated·AstraZeneca··NCT01944618·5,000 enrolled

Details

Drug Info

Related News